Gauging Outcomes of Total Milk Ingestion on Lipid and gControl

This study is looking at how drinking whole milk versus skim milk affects your heart health. Researchers want to see if one type of milk is better for reducing your risk of heart disease. You could be eligible if you are at least 18 years old, use a smartphone, can use the Eureka mobile app, and drink at least one cup of dairy milk most days. You cannot join if you are lactose intolerant, have a history of heart attack or diabetes, or have familial hypercholesterolemia (a genetic condition causing high cholesterol). The main goal is to measure your Hemoglobin A1c (HbA1c), which is a measure of blood sugar control, at 2 and 4 months. The current status of this study is unclear, and it plans to enroll 110 participants.

Study design
This is an interventional study where participants will switch between drinking whole milk and skim milk over two consecutive two-month periods. It plans to enroll 110 participants.
What's involved
You would be instructed to drink either whole milk or skim milk for two months, then switch to the other type for another two months. You will also wear a fitness tracker, use a smart scale and blood pressure monitor weekly, and use a mobile app to track your diet and activity.
Compensation
Not stated in the trial record.
Follow-up
Participants will have lab tests performed at 2 months and 4 months after starting the intervention.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07087184

Gauging Outcomes of Total Milk Ingestion on Lipid and gControl

Recruiting
NAAges 18+InterventionalPrevention
University of California, San Francisco
~110 participants
Updated 2026-07-22 on ClinicalTrials.gov
What's tested:Whole Milk-Skim MilkSkim Milk-Whole Milk

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Hemoglobin A1c (HbA1c)
Measured over Measured at 2 months and 4 months after intervention initiation
Heart Diseases
Cardiovascular Disease
1 sites across 1 states
California1
  • Gregory M Marcus, MD, MAS · PRINCIPAL_INVESTIGATOR · University of California, San Francisco

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Are age ≥18 years
Have a smartphone
Are able to use the Eureka mobile application
Consume, on average, at least one cup of dairy milk daily, at least 5 days per week

Exclusion

Non-English speaker
Are lactose intolerant
History of myocardial infarction
History of type I or type II diabetes
Familial hypercholesterolemia
Plan to change treatment for cholesterol
Unable to read or sign to provide informed consent
  • Hemoglobin A1c (HbA1c)Measured at 2 months and 4 months after intervention initiation

    The primary outcome will be the hemoglobin A1c (HbA1c) measured at the end of each intervention period with whole-fat milk compared to skim milk during the enrollment period.